|
Heres the latest from GSK:
Hi Joe,
The latest US update is that we have 9 sites active and 10 patients enrolled.
As you know sometimes site approval is longer than 2 weeks as it takes a while for contract negotiations, reg doc submissions and IRB approvals.
For patients who are being screened for the study, it could take up to 2 weeks, depending on what testing needs to be done for the patient and the time frame in which these tests can be scheduled.
All patients must have progressive disease with scans done within 2 weeks of study entry to confirm this progression, as well as an ECHO or MUGA scan to confirm that the subject has adequate cardiac function. If these can be done, and results gotten back rather quickly at an institution, the patient could probably be treated in less than 2 weeks. If not, then it could be up to 2 weeks from consent to dosing.
Hope this answers your questions.
Thanks and take care.
Cathy
__________________
A Proud webmaster to the internet's most informed, educated, COMPASSIONATE and caring group of breast cancer survivors.
Illegitimi non carborundum
My Album
|